Accordingly, similar results were obtained from analysis of the TCGA and REMBRANDT databases (Supplementary Figures 4, 5) Taken together, these data indicated that CASP6 may represent a potential prognostic biomarker for patients with glioma. This evidence concerns the gene CASP6 and central nervous system cancer.